Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial

William Greenhalf, Paula Ghaneh, John P. Neoptolemos, Daniel H. Palmer, Trevor F. Cox, Richard F. Lamb, Elizabeth Garner, Fiona Campbell, John R. MacKey, Eithne Costello, Malcolm J. Moore, Juan W. Valle, Alexander C. McDonald, Ross Carter, Niall C. Tebbutt, David Goldstein, Jennifer Shannon, Christos Dervenis, Bengt Glimelius, Mark DeakinRichard M. Charnley, François Lacaine, Andrew G. Scarfe, Mark R. Middleton, Alan Anthoney, Christopher M. Halloran, Julia Mayerle, Attila Oláh, Richard Jackson, Charlotte L. Rawcliffe, Aldo Scarpa, Claudio Bassi, Markus W. Büchler

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Nursing and Health Professions

    Pharmacology, Toxicology and Pharmaceutical Science

    Biochemistry, Genetics and Molecular Biology